QUOTE(Orbz @ Feb 28, 2007, 07:15 PM)

I have yet to see a study showing neurotoxic effects of either psilocybin or LSD. Do you know of any?
I have my own anecdotal evidence from heavy drug users I've known, and also the following from Pubmed:
Int J Addict. 1981 Apr;16(3):527-40. Links
Multiple drug abuse involving nonopiate, nonalcoholic substances. II. Physical damage, long-term psychological effects and treatment approaches and success.
* Kornblith AB.
A review of the literature of multiple drug abuse involving two or more drug categories where at least one is a nonopiate, nonalcoholic substance (MDA NONA) suggested the possibility that sedative-hypnotics were the culpable agent for neuropsychological deficits in this group. Individually, amphetamines and hallucinogens, primarily LSD, have been associated with long-term psychological disturbance. While many abusers of these drugs who develop psychoses have been documented to be emotionally disturbed prior to drug usage, indicating that the drug exacerbated a prepsychotic condition, other abusers have no such history, indicating a drug-induced psychosis. Current treatment approaches appear to be ineffective for MDA-NONA abusers, as indicated by poor retention rates and relapse to drug use.
Granted this study is not very convincing though, and it's surprising that, if psychedelics do cause brain damage, then why isn't there clear-cut evidence demonstrating this.
QUOTE(Orbz @ Feb 28, 2007, 07:15 PM)

Serotonergic agonists (hallucinogens) actually have neuroprotective effects in situations where NMDA antagonists are given.
you're referring to this study?
Neuropsychopharmacology. 1998 Jan;18(1):57-62.Click here to read Links
Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity.
* Farber NB,
* Hanslick J,
* Kirby C,
* McWilliams L,
* Olney JW.
Department of Psychiatry, Washington University, St. Louis, Missouri, USA.
Phencyclidine, ketamine, and other agents that block NMDA glutamate receptors trigger a schizophrenia-like psychosis in humans and induce pathomorphological changes in cerebrocortical neurons in rat brain. Accumulating evidence suggests that a complex network disturbance involving multiple transmitter receptor systems is responsible for the neuronal injury, and it is proposed that a similar network disturbance is responsible for the psychotomimetic effects of NMDA antagonists, and might also be involved in the pathophysiology of schizophrenia. In the present study we present evidence that serotonergic agents possessing 5HT2A agonist activity prevent NMDA antagonist neurotoxicity in rat brain. It is proposed that 5HT2A agonists may also prevent the psychotomimetic effects of NMDA antagonists. Among the 5HT2A agonists examined and found to be neuroprotective are LSD and related hallucinogens. The apparent contradiction in proposing that these agents might have antipsychotic properties is resolved by evidence linking their hallucinogenic activity to agonist action at 5HT2C receptors, whereas antipsychotic activity would be attributable to agonist action at 5HT2A receptors.
I haven't seen clear evidence of how LSD works or even if it has predominantly serotonergic agonist versus antagonist properties, though the above study claims that it's an agonist at 5HT2A. The thing about the above study is that NMDA antagonist neurotoxicity has only been demonstrated in rodents, but has never been demonstrated in primates, to my knowledge.